DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹47,594 Cr | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr |
What is the latest Total Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹47,594 Cr |
| Mar2024 | ₹37,806 Cr |
| Mar2023 | ₹31,580 Cr |
| Mar2022 | ₹28,470 Cr |
| Mar2021 | ₹25,548 Cr |
How is Total Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹47,594 Cr | 25.89 | |
| Mar2024 | ₹37,806 Cr | 19.72 | |
| Mar2023 | ₹31,580 Cr | 10.92 | |
| Mar2022 | ₹28,470 Cr | 11.44 | |
| Mar2021 | ₹25,548 Cr | - | |
Compare Total Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹100,594.3 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| MANKIND PHARMA | ₹93,419.6 Cr | -5% | -8.8% | -14.2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.6% |
-3.5% |
-4.3% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses